2,5-DISUBSTITUTED PYRIDINE, PYRIMIDINE, PYRIDAZINE AND 1, 2, 4-TRIAZINE DERIVATIVES FOR USE AS P38 INHIBITORS
申请人:VERTEX PHARMACEUTICALS INCORPORATED
公开号:EP1392300A1
公开(公告)日:2004-03-03
US7271181B2
申请人:——
公开号:US7271181B2
公开(公告)日:2007-09-18
[EN] 2,5-DISUBSTITUTED PYRIDINE, PYRIMIDINE, PYRIDAZINE AND 1, 2, 4-TRIAZINE DERIVATIVES FOR USE AS P38 INHIBITORS<br/>[FR] DERIVES DE PYRIDINE, PYRIMIDINE, PYRIDAZINE 2,5-DISUBSTITUES ET DE 1, 2, 4-TRIAZINE UTILISES COMME INHIBITEURS DE P38
申请人:VERTEX PHARMA
公开号:WO2002092087A1
公开(公告)日:2002-11-21
The present invention relates to inhibitors of P38, a mammalian protein kinase involved cell proliferation, cell death and response to extracellular stimuli. The invention also relates to methods for producing these inhibitors. The invention also provides pharmaceutical compositions comprising the inhibitors of the invention and methods of utilizing those compositions in the treatment and prevention of various disorders. The inhibitors are of formula (I), (II) or (III) wherein the variables are as defined in the claims.
Inhibitors of p38
申请人:——
公开号:US20030096817A1
公开(公告)日:2003-05-22
The present invention relates to inhibitors of p38, a mammalian protein kinase involved cell proliferation, cell death and response to extracellular stimuli. The invention also relates to methods for producing these inhibitors. The invention also provides pharmaceutical compositions comprising the inhibitors of the invention and methods of utilizing those compositions in the treatment and prevention of various disorders.